FILTER
LATEST INTERVIEWS
David H. Crean
MANAGING DIRECTOR, INVESTMENT BANKING, OBJECTIVE CAPITAL PARTNERS
Objective Capital Partners, headquartered in Southern California, is a leading mergers and acquisitions (M&A) investment banking firm focused on transactions for privately held companies with enterprise values up to US$500 million.
Federico Veller
EXECUTIVE MANAGER CHEMICALS, YPF
“The petrochemicals industry is the sector that will drive hydrocarbons consumption over the next years. Large oil companies forecast flattened fuel demand, and this is why focus is increasingly placed on the petrochemicals business. Those companies that are vertically integrated, with feedstock production all the way to the downstream business, will be the most competitive ones."
Vidya Vasu-Devan
DEPUTY DIRECTOR, BILL & MELINDA GATES FOUNDATION’S STRATEGIC INVESTMENT FUND
The Bill & Melinda Gates Foundation is the largest private foundation in the United States. Its Strategic Investment Fund (SIF) works to leverage the might of the private sector to achieve progress on the foundation’s charitable objectives.
Michel Champagne
PRESIDENT & CEO, SIDEX
A look at investment criteria to support early stage exploration companies in Québec.
Naseem Lahri
MANAGING DIRECTOR, LUCARA BOTSWANA
Lahri gives details about the use of new technologies in diamond mining and the impact of blockchain on traceability.
Raul Rodriguez
PRESIDENT AND CEO, RIGEL
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and commercializing novel small molecule drugs for immune and hematologic disorders, cancer and rare diseases.
Elizabeth Jeffords
CHIEF COMMERCIAL & STRATEGY OFFICER, ALKAHEST
Alkahest has a unique technology platform for elucidating changes in the plasma proteome in healthy aging and in age-related diseases.
Ricardo Diogo
DIRECTOR BUSINESS DEVELOPMENT, OILTANKING
A look at the liquids storage market in Latin America and its potential consolidation.
Michael Quirmbach
CHIEF BUSINESS OFFICER, CORDENPHARMA
CordenPharma is a CDMO supporting pharma and biotech companies, with cGMP facilities across Europe & the US.
Brian Frenzel
CEO, TOSK
Tosk is developing a family of small molecule drugs to prevent the toxic side ef-fects of cancer treatments.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Latin America Petrochemicals and Chemicals 2024 - Digital Interactive
The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.
The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
